Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?

× No keyword cloud information.

11 in total

1. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

Authors: S Yusuf; P Held; C Furberg
Journal: Am J Cardiol Date: 1991-06-01 Impact factor: 2.778

2. Sublingual nifedipine for hypertensive emergencies.

Authors: F H Messerli; P Kowey; T Grodzicki
Journal: Lancet Date: 1991-10-05 Impact factor: 79.321

3. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies.

Authors: J J O'Mailia; G E Sander; T D Giles
Journal: Ann Intern Med Date: 1987-08 Impact factor: 25.391

4. Surgical bleeding: unexpected effect of a calcium antagonist.

Authors: L E Wagenknecht; C D Furberg; J W Hammon; C Legault; B T Troost
Journal: BMJ Date: 1995-03-25

5. Verapamil following uncomplicated myocardial infarction: promising, but not proven.

Authors: S Yusuf
Journal: Am J Cardiol Date: 1996-02-15 Impact factor: 2.778

6. Apparatchiks of science share their anxiety.

Authors: D S Greenberg
Journal: Lancet Date: 1995-09-09 Impact factor: 79.321

Review 7. Calcium antagonists during and after myocardial infarction.

Authors: P Sleight
Journal: Drugs Date: 1996-02 Impact factor: 9.546

8. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

Authors: C D Furberg; B M Psaty; J V Meyer
Journal: Circulation Date: 1995-09-01 Impact factor: 29.690

9. Long-term survival and use of antihypertensive medications in older persons.

Authors: M Pahor; J M Guralnik; M C Corti; D J Foley; P Carbonin; R J Havlik
Journal: J Am Geriatr Soc Date: 1995-11 Impact factor: 5.562

10. Established populations for epidemiologic studies of the elderly: study design and methodology.

Authors: J Cornoni-Huntley; A M Ostfeld; J O Taylor; R B Wallace; D Blazer; L F Berkman; D A Evans; F J Kohout; J H Lemke; P A Scherr
Journal: Aging (Milano) Date: 1993-02

3 in total

1. Evidence for the risk of calcium channel blockers in hypertension was selective.

Authors: F W Hanna; J R Peters; J A Rees
Journal: BMJ Date: 1996-11-16

Review 2. The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Authors: P Sleight
Journal: Curr Cardiol Rep Date: 2001-11 Impact factor: 2.931

Review 3. Amlodipine and valsartan as components of a rational and effective fixed-dose combination.

Authors: Bernard Waeber; Luis M Ruilope
Journal: Vasc Health Risk Manag Date: 2009-04-08

3 in total